Acquisition by Leonard Braden Michael of 36176 shares of Reneo Pharmaceuticals at 1.3966 subject to Rule 16b-3
RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of RPHM Old's investors are presently thinking to get in. The analysis of current outlook of investing in RPHM Old suggests that some traders are interested regarding RPHM Old's prospects. RPHM Old's investing sentiment overview a quick insight into current market opportunities from investing in RPHM Old. Many technical investors use RPHM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RPHM |
Filed transaction by Reneo Pharmaceuticals 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
RPHM Old Fundamental Analysis
We analyze RPHM Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RPHM Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RPHM Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
RPHM Old is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
RPHM Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RPHM Old stock to make a market-neutral strategy. Peer analysis of RPHM Old could also be used in its relative valuation, which is a method of valuing RPHM Old by comparing valuation metrics with similar companies.
Peers
RPHM Old Related Equities
SMMT | Summit Therapeutics | 14.61 | ||||
DNA | Ginkgo Bioworks | 6.93 | ||||
EWTX | Edgewise Therapeutics | 4.30 | ||||
VIR | Vir Biotechnology | 2.97 | ||||
CNSP | Cns Pharmaceuticals | 2.60 | ||||
CELC | Celcuity LLC | 2.56 | ||||
CGEM | Cullinan Oncology | 1.36 | ||||
PRME | Prime Medicine, | 1.04 | ||||
KRON | Kronos Bio | 0.98 | ||||
KZR | Kezar Life | 0.81 | ||||
NKTX | Nkarta | 0.41 | ||||
CCCC | C4 Therapeutics | 0.25 | ||||
APLS | Apellis Pharmaceuticals | 0.20 | ||||
HOWL | Werewolf Therapeutics | 0.00 | ||||
ADPT | Adaptive Biotechnologies | 0.00 | ||||
LEGN | Legend Biotech | 0.00 | ||||
RPRX | Royalty Pharma | 0.00 | ||||
IMMX | Immix Biopharma | 1.47 | ||||
OCEA | Ocean Biomedical | 10.83 | ||||
HEPA | Hepion Pharmaceuticals | 31.53 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in RPHM Stock
If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bonds Directory Find actively traded corporate debentures issued by US companies |